A Systematic Review Anti Diabetic Drug And Their Management Therapies

Abstract

After epilepsy and asthma, diabetes is the third most prevalent chronic condition in children. More lately, there has been a sharp rise in the general prevalence of diabetes in both adults and children. This has been partly caused by the obesity pandemic in children. It makes sense that this placed a financial strain on nations and health authorities who were coping with high rates of illness morbidity and possibly dangerous sequelae. Simultaneously, other therapeutic discoveries broadened the selection of available drugs. We speculate that an authority requests a report of anti- diabetic medication prioritizing from specialized specialists. Apart from insulin and metformin, some people might have another option for a third drug, and doctors may have more than three options available to them at any given moment many clinical settings. The new policy of the authority is to buy only three antidiabetic pharmaceutic also out of a big list of both new and old meds. In response to this request, we provided a recommendation based on the most extensive clinical research in the field as well a various qualities of these drugs.